Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Wenzel

Showing results (81-90 of 213) with videos related to

Pageof 22
Sort By:
Clinics (Sao Paulo, Brazil)|October 2, 2023
Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: An observational studysCristina Cano Garcia, Mike Wenzel, Florestan Koll, et al.
Deutsches Arzteblatt International|June 24, 2025
Radical Prostatectomy Versus Radiotherapy for Prostate Cancer: Stage-, Age-, and Frailty-Specific Cancer-Control Outcomes of 2600 PatientsMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 6, 2025
Real world comparison of adjuvant vs. salvage radiation therapy on cancer-control outcomes after radical prostatectomyMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
Frontiers in Oncology|February 15, 2021
Comparison Between Urothelial and Non-Urothelial Urethral CancerMike Wenzel, Marina Deuker, Luigi Nocera, et al.
BJU International|July 10, 2024
Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancerMike Wenzel, Benedikt Hoeh, Florestan Koll, et al.
Clinical Genitourinary Cancer|August 6, 2024
Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer PatientsMike Wenzel, Malin Lutz, Benedikt Hoeh, et al.
Urologic Oncology|December 14, 2020
The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancerMike Wenzel, Marina Deuker, Franziska Stolzenbach, et al.
Cancers|November 9, 2024
The Association Between Lymphovascular or Perineural Invasion in Radical Prostatectomy Specimen and Biochemical RecurrenceCarolin Siech, Mike Wenzel, Nico Grosshans, et al.
Journal of Clinical Pathology|November 21, 2023
Impact of consensus molecular subtypes on survival with and without adjuvant chemotherapy in muscle-invasive urothelial bladder cancerFlorestan J Koll, Claudia Döring, Leon Herwig, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 16, 2021
Life expectancy in metastatic prostate cancer patients according to racial/ethnic groupsChristoph Würnschimmel, Mike Wenzel, Claudia Collà Ruvolo, et al.
Pageof 22

Showing results (81-90 of 213) with videos related to

Sort By:
Pageof 22
Clinics (Sao Paulo, Brazil)|October 2, 2023
Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: An observational studysCristina Cano Garcia, Mike Wenzel, Florestan Koll, et al.
Deutsches Arzteblatt International|June 24, 2025
Radical Prostatectomy Versus Radiotherapy for Prostate Cancer: Stage-, Age-, and Frailty-Specific Cancer-Control Outcomes of 2600 PatientsMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 6, 2025
Real world comparison of adjuvant vs. salvage radiation therapy on cancer-control outcomes after radical prostatectomyMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
Frontiers in Oncology|February 15, 2021
Comparison Between Urothelial and Non-Urothelial Urethral CancerMike Wenzel, Marina Deuker, Luigi Nocera, et al.
BJU International|July 10, 2024
Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancerMike Wenzel, Benedikt Hoeh, Florestan Koll, et al.
Clinical Genitourinary Cancer|August 6, 2024
Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer PatientsMike Wenzel, Malin Lutz, Benedikt Hoeh, et al.
Urologic Oncology|December 14, 2020
The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancerMike Wenzel, Marina Deuker, Franziska Stolzenbach, et al.
Cancers|November 9, 2024
The Association Between Lymphovascular or Perineural Invasion in Radical Prostatectomy Specimen and Biochemical RecurrenceCarolin Siech, Mike Wenzel, Nico Grosshans, et al.
Journal of Clinical Pathology|November 21, 2023
Impact of consensus molecular subtypes on survival with and without adjuvant chemotherapy in muscle-invasive urothelial bladder cancerFlorestan J Koll, Claudia Döring, Leon Herwig, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 16, 2021
Life expectancy in metastatic prostate cancer patients according to racial/ethnic groupsChristoph Würnschimmel, Mike Wenzel, Claudia Collà Ruvolo, et al.
Pageof 22